Investigation Overview
Sept. 18, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Complete Genomics, Inc. (NASDAQ:GNOM) shares was announced concerning whether the offer by BGI-Shenzhen to acquire Complete Genomics, Inc. for $3.15 per NASDAQ:GNOM share and the takeover process are unfair to investors in Complete Genomics shares. The investigation by a law firm concerns whether c...
You must register (for free) or login to view the entire investigation.